HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of prediction models for the sensitivity of oral squamous cell carcinomas to preoperative S-1 administration.

Abstract
S-1 is an anticancer agent that is comprised of tegafur, gimeracil, and oteracil potassium, and is widely used in various carcinomas including oral squamous cell carcinoma (OSCC). Although an established prediction tool is not available, we aimed to develop prediction models for the sensitivity of primary OSCC cases to the preoperative administration of S-1. We performed DNA microarray analysis of 95 cases with OSCC. Using global gene expression data and the clinical data, we developed two different prediction models, namely, model 1 that comprised the complete response (CR) + the partial response (PR) versus stable disease (SD) + progressive disease (PD), and model 2 that comprised responders versus non-responders. Twelve and 18 genes were designated as feature genes (FGs) in models 1 and 2, respectively, and, of these, six genes were common to both models. The sensitivity was 96.3%, the specificity was 91.2%, and the accuracy was 92.6% for model 1, and the sensitivity was 95.6%, the specificity was 85.2%, and the accuracy was 92.6% for model 2. These models were validated using receiver operating characteristic analysis, and the areas under the curves were 0.967 and 0.949 in models 1 and 2, respectively. The data led to the development of models that can reliably predict the sensitivity of patients with OSCC to the preoperative administration of S-1. The mechanism that regulates S-1 sensitivity remains unclear; however, the prediction models developed provide hope that further functional investigations into the FGs will lead to a greater understanding of drug resistance.
AuthorsMasashi Shiiba, Hitomi Yamagami, Tadashi Sudo, Yosuke Tomokuni, Daisuke Kashiwabara, Tadaaki Kirita, Jingo Kusukawa, Masamichi Komiya, Kanchu Tei, Yoshimasa Kitagawa, Yutaka Imai, Hitoshi Kawamata, Hiroki Bukawa, Kazuhito Satomura, Hidero Oki, Keiji Shinozuka, Kazumasa Sugihara, Tsuyoshi Sugiura, Joji Sekine, Hidetaka Yokoe, Kengo Saito, Hideki Tanzawa
JournalHeliyon (Heliyon) Vol. 6 Issue 8 Pg. e04601 (Aug 2020) ISSN: 2405-8440 [Print] England
PMID32793829 (Publication Type: Journal Article)
Copyright© 2020 The Authors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: